YILDIZ, Mustafa.
 Long-acting injectable antipsychotics for schizophrenia treatment: optimal duration from a cost-effectiveness standpoint.
<strong>Medical Research Archives</strong>, [S.l.], v. 14, n. 3, apr. 2026.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/7354" target="_new">https://esmed.org/MRA/mra/article/view/7354</a>&gt;. Date accessed: 06 apr. 2026.
doi: <a href="https://doi.org/10.18103/mra.v14i3.7354">https://doi.org/10.18103/mra.v14i3.7354</a>.